Inmune Bio (INMB) Non Operating Interest Expenses (2021 - 2023)

Inmune Bio has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $29000.0 for Q4 2023.

• In Q4 2023, Non Operating Interest Expenses fell 84.82% year-over-year to $29000.0; the TTM figure through Dec 2023 stood at $267000.0 (down 80.19% YoY), while the FY2023 annual figure was $267000.0, down 80.19% from the prior year.
• Non Operating Interest Expenses came in at $29000.0 for Q4 2023 at Inmune Bio, down from $35000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $641000.0 in Q4 2021 to a low of $29000.0 in Q4 2023.
• Average Non Operating Interest Expenses over 3 years is $254000.0, with a median of $191000.0 recorded in 2022.
• Year-over-year, Non Operating Interest Expenses jumped 345.54% in 2022 and tumbled 87.59% in 2023.
• Over 3 years, Non Operating Interest Expenses stood at $641000.0 in 2021, then tumbled by 70.2% to $191000.0 in 2022, then slumped by 84.82% to $29000.0 in 2023.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $29000.0 in Q4 2023, $35000.0 in Q3 2023, and $90000.0 in Q2 2023.